DMAPT‑D6 induces death‑receptor‑mediated apoptosis to inhibit glioblastoma cell oncogenesis via induction of DNA damage through accumulation of intracellular ROS

  • Authors:
    • Ya‑Jun Zhang
    • Dong‑Lin Yang
    • Hong‑Xia Qin
    • Liu‑Jun He
    • Jiu‑Hong Huang
    • Dian‑Yong Tang
    • Zhi‑Gang Xu
    • Zhong‑Zhu Chen
    • Yong Li
  • View Affiliations

  • Published online on: January 12, 2021     https://doi.org/10.3892/or.2021.7932
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Glioblastoma (GBM) is an aggressive malignancy with a high rate of tumor recurrence after treatment with conventional therapies. Parthenolide (PTL), a sesquiterpene lactone extracted from the herb Tanacetum parthenium or feverfew, possesses anticancer properties against a wide variety of solid tumors. In the present study, a series of PTL derivatives were synthesized and screened. An inhibitor, dimethylaminoparthenolide (DMAPT)‑D6, a derivative of the PTL prodrug DMAPT in which the hydrogen of the dimethylamino group is substituted for the isotope deuterium, induced significant cytotoxicity in GBM cells in vitro and induced cell cycle arrest at the S‑phase in a dose‑dependent manner. Furthermore, mechanistic investigation indicated that through increasing the levels of intracellular accumulation of reactive oxygen species (ROS), DMAPT‑D6 triggered DNA damage and finally death receptor‑mediated extrinsic apoptosis in GBM cells, suggesting that DNA damage induced by DMAPT‑D6 initiated caspase‑dependent apoptosis to remove damaged GBM cells. Taken together, these data suggested that ROS accumulation following treatment with DMAPT‑D6 results in DNA damage, and thus, death‑receptor‑mediated apoptosis, highlighting the potential of DMAPT‑D6 as a novel therapeutic agent for the treatment of GBM.

Related Articles

Journal Cover

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang YJ, Yang DL, Qin HX, He LJ, Huang JH, Tang DY, Xu ZG, Chen ZZ and Li Y: DMAPT‑D6 induces death‑receptor‑mediated apoptosis to inhibit glioblastoma cell oncogenesis via induction of DNA damage through accumulation of intracellular ROS. Oncol Rep 0: 0-0, 1899
APA
Zhang, Y., Yang, D., Qin, H., He, L., Huang, J., Tang, D. ... Li, Y. (1899). DMAPT‑D6 induces death‑receptor‑mediated apoptosis to inhibit glioblastoma cell oncogenesis via induction of DNA damage through accumulation of intracellular ROS. Oncology Reports, 0, 0-0. https://doi.org/10.3892/or.2021.7932
MLA
Zhang, Y., Yang, D., Qin, H., He, L., Huang, J., Tang, D., Xu, Z., Chen, Z., Li, Y."DMAPT‑D6 induces death‑receptor‑mediated apoptosis to inhibit glioblastoma cell oncogenesis via induction of DNA damage through accumulation of intracellular ROS". Oncology Reports 0.0 (1899): 0-0.
Chicago
Zhang, Y., Yang, D., Qin, H., He, L., Huang, J., Tang, D., Xu, Z., Chen, Z., Li, Y."DMAPT‑D6 induces death‑receptor‑mediated apoptosis to inhibit glioblastoma cell oncogenesis via induction of DNA damage through accumulation of intracellular ROS". Oncology Reports 0, no. 0 (1899): 0-0. https://doi.org/10.3892/or.2021.7932